Immix Biopharma (IMMX) Shares Issued (2020 - 2026)

Immix Biopharma (IMMX) has 7 years of Shares Issued data on file, last reported at $5.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued rose 30.44% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (up 30.44% YoY), and the FY2025 full-year result was $5.3 million, up 29.47% from the prior year.
• Shares Issued rose to $5.3 million in Q1 2026, from $5.3 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $5.3 million in Q1 2026 to a low of $1.2 million in Q2 2022.
• A 5-year average of $3.2 million and a median of $2.5 million in 2023 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued rose 0.57% in 2022 and surged 125.83% in 2024, its largest moves.
• Tracing IMMX's Shares Issued over 5 years: stood at $1.8 million in 2022, then surged by 41.85% to $2.5 million in 2023, then jumped by 61.83% to $4.1 million in 2024, then grew by 29.47% to $5.3 million in 2025, then advanced by 1.37% to $5.3 million in 2026.
• Business Quant data shows IMMX's Shares Issued at $5.3 million in Q1 2026, $5.3 million in Q4 2025, and $4.9 million in Q3 2025.